We use cookies to improve your experience. See our Privacy Policy.
Anika Therapeutics, Inc. is a surgical & medical instruments & apparatus company incorporated in DE, trading on the Nasdaq.
Brefyr has analyzed 2 SEC filings for ANIK, with the most recent being a 10-Q filed on November 6, 2026. Each filing is scored for significance on a 1-10 scale to help investors quickly identify the most important disclosures.
Exchange
Nasdaq
Sector
Healthcare
Filer Category
Accelerated filer
Fiscal Year End
December
Anika Therapeutics, Inc. is a surgical & medical instruments & apparatus company incorporated in DE, trading on the Nasdaq.
Brefyr has analyzed 2 SEC filings for ANIK, including 10-Q, 8-K. The most recent filing was a 10-Q filed on November 6, 2026.
No recent insider transactions have been detected in ANIK SEC filings.
Anika Therapeutics, Inc. is incorporated in DE and is classified as a Accelerated filer filer with the SEC.
Anika Therapeutics, Inc.'s fiscal year ends in December. Annual 10-K reports are typically filed within 60-90 days after the fiscal year end.
Last updated: November 6, 2026
Data sourced from SEC EDGAR public filings. For informational purposes only — not investment advice. AI-generated summaries may contain errors. See our full disclaimer.